Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FQP9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,899
Award facts
- Contract value 100% obligated
- $23,899.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,899.10 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. XELJANZ XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions, representing AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that provides comprehensive global pharmaceutical and medical supply support to military healthcare programs. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitive delivery orders demonstrates its capability to meet federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FQP9Q?
SPE2DR26FQP9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQP9Q worth?
The government has obligated $23,899 on SPE2DR26FQP9Q.
Is contract SPE2DR26FQP9Q an order under another contract?
Yes. SPE2DR26FQP9Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP9Q competed?
The extent of competition for SPE2DR26FQP9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award